share_log

Recursion Pharmaceuticals(RXRX.US) Director Sells US$87,725.23 in Common Stock

moomoo News ·  Apr 18 17:56

$Recursion Pharmaceuticals (RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on Apr 16, 2024 at an average price of $7.6636 for a total value of $87,725.23.

1713477364518615499.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment